Josée Golay, Greta Ubiali, and Martino Introna. 2017. “The Specific Bruton Tyrosine Kinase Inhibitor Acalabrutinib (ACP-196) Shows Favorable in Vitro Activity Against Chronic Lymphocytic Leukemia B Cells With CD20 Antibodies”. Haematologica 102 (10). Pavia, Italy, e400-e403. https://doi.org/10.3324/haematol.2017.169334.